Cubist Systematic Strategies, LLC Durect Corp Transaction History

Cubist Systematic Strategies, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.38 - $0.64 $7,885 - $13,280	20,751 New	20,751 $10,000
Q3 2020 Nov 16, 2020	SELL	$1.6 - $2.35 $28,544 - $41,924	-17,840 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.33 - $2.76 $23,727 - $49,238	17,840 New	17,840 $41,000
Q1 2020 May 15, 2020	SELL	$0.97 - $2.85 $30,097 - $88,429	-31,028 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.69 - $3.8 $54,575 - $122,713	-32,293 Reduced 51.0%	31,028 $118,000
Q3 2019 Nov 14, 2019	BUY	$0.61 - $2.21 $38,625 - $139,939	63,321 New	63,321 $117,000
Q3 2018 Nov 14, 2018	SELL	$1.06 - $1.69 $23,753 - $37,871	-22,409 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$1.56 - $2.51 $60,278 - $96,986	-38,640 Reduced 63.29%	22,409 $35,000
Q1 2018 May 15, 2018	BUY	$0.91 - $2.24 $55,554 - $136,749	61,049 New	61,049 $131,000
Q4 2017 Feb 14, 2018	SELL	$0.78 - $2.1 $12,866 - $34,639	-16,495 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.55 - $1.82 $25,567 - $30,020	16,495	16,495 $29,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $194M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.